Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-26-032911
Filing Date
2026-03-23
Accepted
2026-03-23 16:01:12
Documents
1
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1752
  Complete submission text file 0001213900-26-032911.txt   3183
Mailing Address 26 BEN-GURION ST. RAMAT GAN L3 5112001
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Issuer) CIK: 0001023549 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 26 BEN-GURION ST. RAMAT GAN Israel 5112001
Business Address
Segal Niv (Reporting) CIK: 0002121739 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36000 | Film No.: 26782051